Verrica Pharmaceuticals Inc (NAS:VRCA)
$ 6.26 -0.31 (-4.72%) Market Cap: 107.54 Mil Enterprise Value: 88.38 Mil PE Ratio: 0 PB Ratio: 6.66 GF Score: 41/100

Verrica Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 03:30 PM GMT
Release Date Price: $5.37 (-1.83%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VRCA.OQ - Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, good morning. Thanks so much for joining our forty-sixth annual healthcare conference. I'm Stacy Ku, one of the biotech analysts at TD Cowan, and I'm joined by my colleague Bish Shaw. We're very happy to be hosting the Berrica team with us today. We have Jason Riegger, CEO. In the crowd we have John Kriby, CFO.

So now having stepped into the YCAT relaunch for Molluscum Cadiziosum, now about a year ago, looking forward to hearing about the progress.

This is very loud. Apologize, guys.

Thank you.

So before we dig into maybe all the different nuances around the relatch and remind us what is the value proposition of Yanth and molluscum and what's the real big unmet
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot